Research
B. Riley Initiates 4D Molecular Therapeutics at Buy With $37 Price Target
4D Molecular Therapeutics (FDMT) has an average rating of buy and mean price target of $28.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $10.27, Change: $+0.20, Percent Change: +1.99%
$FDMT
